Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

ACCP

ACCELERATED PHARMA, INC. (ACCP)

Accelerated Pharma (MM)
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ACCP
일자시간출처헤드라인심볼기업
2020/04/2301:45Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACCPAccelerated Pharma (MM)
2020/02/0623:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACCPAccelerated Pharma (MM)
2020/02/0601:33Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACCPAccelerated Pharma (MM)
2019/11/0820:00Edgar (US Regulatory)Effectiveness Order (effect)NASDAQ:ACCPAccelerated Pharma (MM)
2019/11/0620:06Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
2019/10/2119:02Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
2019/07/2419:02Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
2019/01/2606:29Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
2018/10/2219:06Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:ACCPAccelerated Pharma (MM)
2017/08/2401:10Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:ACCPAccelerated Pharma (MM)
2017/07/1306:27Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
2017/06/3019:04Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
2017/04/2619:03Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
2017/04/1903:22Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:ACCPAccelerated Pharma (MM)
2017/04/1901:59Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
2017/03/2903:18Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
2016/12/1303:27Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:ACCPAccelerated Pharma (MM)
2016/12/1222:31Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
2010/02/0423:00PR Newswire (US)Access Pharmaceuticals Initiates Program Applying Cobalamin Platform to siRNA Drug DeliveryNASDAQ:ACCP
2010/02/0305:22PR Newswire (US)Access Pharmaceuticals Announces Closing of $6.3 Million in Registered Direct OfferingNASDAQ:ACCP
2010/01/2223:29PR Newswire (US)Access Pharmaceuticals Raises $6.3 Million In Registered Direct OfferingNASDAQ:ACCP
2010/01/1923:00PR Newswire (US)Access Pharmaceutical's Cobalamin Oral Insulin Achieves Greater Than 80% Oral Bioavailability In Preclinical ModelsNASDAQ:ACCP
2010/01/0722:30PR Newswire (US)Access Pharmaceuticals Announces Completion of ProLindac Monotherapy Trial and Initiation of Combination StudyNASDAQ:ACCP
2010/01/0623:00PR Newswire (US)Access Pharmaceuticals To Present at OneMedPlace Forum 2010NASDAQ:ACCP
2009/12/1523:00PR Newswire (US)Access Pharmaceuticals Appoints Sales and Marketing ExecutiveNASDAQ:ACCP
2009/12/0402:48PR Newswire (US)Access Pharmaceuticals Provides Update on MuGard Commercial Launch in EuropeNASDAQ:ACCP
2009/11/1723:00PR Newswire (US)ChangeWave Issues Buy Recommendation on Access PharmaceuticalsNASDAQ:ACCP
2009/11/1123:00PR Newswire (US)Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North AmericaNASDAQ:ACCP
2009/10/1521:00PR Newswire (US)Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians FeedbackNASDAQ:ACCP
2009/10/0621:00PR Newswire (US)Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM)NASDAQ:ACCP
 검색 관련기사 보기:NASDAQ:ACCP